Medidata Solutions, Inc. (MDSO) Given Average Rating of “Buy” by Brokerages
Medidata Solutions, Inc. (NASDAQ:MDSO) has been assigned a consensus recommendation of “Buy” from the thirteen ratings firms that are currently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 1-year price target among analysts that have covered the stock in the last year is $84.64.
A number of equities research analysts recently weighed in on MDSO shares. Jefferies Group LLC restated a “hold” rating and set a $78.00 price objective on shares of Medidata Solutions in a research note on Tuesday, August 22nd. Morgan Stanley set a $74.00 price objective on Medidata Solutions and gave the company a “buy” rating in a research report on Wednesday, June 14th. Royal Bank Of Canada initiated coverage on Medidata Solutions in a research note on Tuesday, September 19th. They issued a “sector perform” rating and a $82.00 target price on the stock. Zacks Investment Research upgraded Medidata Solutions from a “sell” rating to a “hold” rating in a research note on Wednesday, September 20th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $90.00 target price (up from $75.00) on shares of Medidata Solutions in a report on Friday, July 21st.
In other Medidata Solutions news, COO Michael L. Capone sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $74.53, for a total transaction of $372,650.00. The transaction was disclosed in a filing with the SEC, which is available at this link. 5.80% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently bought and sold shares of the business. World Asset Management Inc acquired a new stake in shares of Medidata Solutions during the first quarter worth $201,000. UBS Asset Management Americas Inc. increased its position in shares of Medidata Solutions by 16.7% in the 1st quarter. UBS Asset Management Americas Inc. now owns 29,724 shares of the company’s stock valued at $1,715,000 after acquiring an additional 4,251 shares during the period. Karp Capital Management Corp acquired a new position in shares of Medidata Solutions in the 1st quarter valued at $641,000. Sei Investments Co. increased its position in shares of Medidata Solutions by 18.9% in the 1st quarter. Sei Investments Co. now owns 35,919 shares of the company’s stock valued at $2,073,000 after acquiring an additional 5,709 shares during the period. Finally, Parametric Portfolio Associates LLC increased its position in shares of Medidata Solutions by 1.8% in the 1st quarter. Parametric Portfolio Associates LLC now owns 91,576 shares of the company’s stock valued at $5,283,000 after acquiring an additional 1,618 shares during the period. 97.52% of the stock is owned by institutional investors and hedge funds.
Shares of Medidata Solutions (NASDAQ:MDSO) traded down 0.33% during mid-day trading on Wednesday, reaching $79.68. 220,332 shares of the company traded hands. The firm has a 50 day moving average of $74.94 and a 200-day moving average of $71.83. Medidata Solutions has a 52 week low of $46.10 and a 52 week high of $85.92. The stock has a market capitalization of $4.51 billion, a PE ratio of 128.72 and a beta of 1.77.
Medidata Solutions (NASDAQ:MDSO) last announced its earnings results on Tuesday, July 18th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.03. Medidata Solutions had a return on equity of 11.14% and a net margin of 7.07%. The business had revenue of $137.41 million for the quarter, compared to analysts’ expectations of $134.28 million. During the same quarter last year, the firm earned $0.24 EPS. The business’s revenue for the quarter was up 19.9% on a year-over-year basis. On average, equities research analysts expect that Medidata Solutions will post $1.29 EPS for the current fiscal year.
About Medidata Solutions
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.